April 24, 2019April 23, 2019
Following My Diagnosis, Negative Thoughts Consumed Me
Columns, Gonna Live My Life by Mark Koziol
Even before I received my official diagnosis of idiopathic pulmonary fibrosis (IPF), the thought of death consumed ... Read more
April 24, 2019April 24, 2019
Indalo Therapeutics Starts Phase 1 Trial Testing Antifibrotic Candidate IDL-2965
News
Indalo Therapeutics has launched a Phase 1 clinical trial testing the company’s lead antifibrotic candidate IDL-2965 for patients with ... Read more
April 23, 2019April 23, 2019
Despite Benefits, Many IPF Patients Switching from Esbriet to Ofev Stop Treatment, Possibly Due to Low BMI, Study Says
News
Many patients with idiopathic pulmonary fibrosis (IPF) who are switching from Esbriet (pirfenidone) to Ofev (nintedanib) discontinue treatment, ... Read more
April 22, 2019April 22, 2019
PFF Summit 2019 in Texas to Present the Latest Research Affecting the PF Community
News
The pulmonary fibrosis (PF) community is invited to attend the Pulmonary Fibrosis Foundation‘s PFF Summit, which is the ... Read more
April 18, 2019April 17, 2019
Lessons I’ve Learned Since My IPF Diagnosis 3 Years Ago
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
We learn the most important lessons in the most difficult times, and I’m grateful to have had opportunities to ... Read more
April 17, 2019April 17, 2019
Rare Gene Variants Linked to Worse Lung Transplant Outcomes in PF Patients
News
Rare variants in genes that regulate the end regions of chromosomes — called telomeres — are linked with worse ... Read more
April 17, 2019April 16, 2019
Finding Support While Going Through Difficult Times
Columns, Gonna Live My Life by Mark Koziol
Before receiving my official diagnosis of idiopathic pulmonary fibrosis (IPF), I was confident in my knowledge of ... Read more
April 16, 2019April 16, 2019
IPF Patients Live Longer on Ofev Compared with Placebo, Analysis Suggests
News
Treatment with Ofev (nintedanib) can significantly extend the survival of patients with idiopathic pulmonary fibrosis (IPF), an analysis ... Read more
April 15, 2019April 15, 2019
Northwestern Doctor Awarded ATS Foundation/Boehringer Ingelheim Fellowship for IPF Research
News
The American Thoracic Society (ATS) Foundation and Boehringer Ingelheim have awarded a physician scientist at Northwestern University this year’s research grant ... Read more
April 12, 2019
10 Exercise Myths and Truths: Advice from a Respiratory Specialist
News
Myth 1: If you can’t run with the big dogs, stay on the porch. Truth: In the words of ... Read more
April 12, 2019April 12, 2019
Phase 1 Trial Testing PLN-74809 Supports its Clinical Development for IPF Treatment, Pliant Announces
News
Pliant Therapeutics has successfully completed a Phase 1 clinical study assessing its investigational therapy PLN-74809 for idiopathic pulmonary ... Read more
April 11, 2019April 18, 2019
The ‘Logan Boulet Effect’ and Its Impact on Patients with PF
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
Most Canadians will remember where they were when they heard the news of the Humboldt Broncos bus crash on ... Read more

April 24, 2019April 23, 2019

Following My Diagnosis, Negative Thoughts Consumed Me

Columns, Gonna Live My Life by Mark Koziol

Even before I received my official diagnosis of idiopathic pulmonary fibrosis (IPF), the thought of death consumed me. I had trouble sleeping. I would lie awake at night for ... Read more

April 24, 2019April 24, 2019

Indalo Therapeutics Starts Phase 1 Trial Testing Antifibrotic Candidate IDL-2965

News

Indalo Therapeutics has launched a Phase 1 clinical trial testing the company’s lead antifibrotic candidate IDL-2965 for patients with fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and nonalcoholic steatohepatitis ... Read more

April 23, 2019April 23, 2019

Despite Benefits, Many IPF Patients Switching from Esbriet to Ofev Stop Treatment, Possibly Due to Low BMI, Study Says

News

Many patients with idiopathic pulmonary fibrosis (IPF) who are switching from Esbriet (pirfenidone) to Ofev (nintedanib) discontinue treatment, especially if they are underweight or have anorexia while being treated with Esbriet, ... Read more

April 22, 2019April 22, 2019

PFF Summit 2019 in Texas to Present the Latest Research Affecting the PF Community

News

The pulmonary fibrosis (PF) community is invited to attend the Pulmonary Fibrosis Foundation‘s PFF Summit, which is the largest healthcare meeting on PF, offering data on the latest research. ... Read more

April 18, 2019April 17, 2019

Lessons I’ve Learned Since My IPF Diagnosis 3 Years Ago

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

We learn the most important lessons in the most difficult times, and I’m grateful to have had opportunities to live those lessons and share them with others. An internet ... Read more

April 17, 2019April 17, 2019

Rare Gene Variants Linked to Worse Lung Transplant Outcomes in PF Patients

News

Rare variants in genes that regulate the end regions of chromosomes — called telomeres — are linked with worse survival rates after lung transplant in pulmonary fibrosis (PF) patients, ... Read more

April 17, 2019April 16, 2019

Finding Support While Going Through Difficult Times

Columns, Gonna Live My Life by Mark Koziol

Before receiving my official diagnosis of idiopathic pulmonary fibrosis (IPF), I was confident in my knowledge of it. Since it was suggested as a potential diagnosis, I spent many ... Read more

April 16, 2019April 16, 2019

IPF Patients Live Longer on Ofev Compared with Placebo, Analysis Suggests

News

Treatment with Ofev (nintedanib) can significantly extend the survival of patients with idiopathic pulmonary fibrosis (IPF), an analysis of pooled data from six clinical trials shows. The analyis, conducted by ... Read more

April 15, 2019April 15, 2019

Northwestern Doctor Awarded ATS Foundation/Boehringer Ingelheim Fellowship for IPF Research

News

The American Thoracic Society (ATS) Foundation and Boehringer Ingelheim have awarded a physician scientist at Northwestern University this year’s research grant in idiopathic pulmonary fibrosis (IPF). Paul Andrew Reyfman, MD, was ... Read more

April 12, 2019

10 Exercise Myths and Truths: Advice from a Respiratory Specialist

News

Myth 1: If you can’t run with the big dogs, stay on the porch. Truth: In the words of the late great Dr. Martin Luther King Jr., “if you ... Read more

April 12, 2019April 12, 2019

Phase 1 Trial Testing PLN-74809 Supports its Clinical Development for IPF Treatment, Pliant Announces

News

Pliant Therapeutics has successfully completed a Phase 1 clinical study assessing its investigational therapy PLN-74809 for idiopathic pulmonary fibrosis (IPF), with results supporting further clinical development of the compound. ... Read more

April 11, 2019April 18, 2019

The ‘Logan Boulet Effect’ and Its Impact on Patients with PF

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

Most Canadians will remember where they were when they heard the news of the Humboldt Broncos bus crash on April 6, 2018. The Saskatchewan-based hockey team was traveling to ... Read more